CAREER HIGHLIGHTS * Raised over $125 million in private and public financings. * Successfully completed over 100 licensing, M&A, collaboration and partnership arrangements including industry transitional agreement with Ubisoft. * Licensed lead Phase I compound for more than $240 million in upfront and milestone payments plus clinical reimbursement and high double digit royalties. * Presented scientific and business overviews at Bio, Bio-Partnering, Pharma-Biotech PLM, Orion Securities, FBR and AAO conferences. * Successfully transformed a concept into a public company through an IPO and maintained Sarbanes-Oxley compliance. * Developed and marketed a line of diagnostic products internationally to the hospital and clinical markets * Actively coordinated the clinical development of five compounds from Preclinical through to Phase III trials. * Successfully commercialized a line of diagnostic products through international distributors. * Raised over $125 million in equity financing. AREAS OF EXPERTISE STRATEGIC PLANNING LICENSING M & A FINANCE PATENTS CORPORATE DEV. SECURITIES START UP ORGANIZATIONS NEGOTIATIONS MARKET ANALYSIS DUE DILIGENCE HEALTHCARE INTL. TRANSACTIONS DISTRIBUTION PARTNERSHIP MGMT

Highlights:

• Therapy
• Venture Capital
• Licensing
• Business Development
• Financial Industry
• Management
• A SERIES
• Civil Litigation
• Diagnostics
• Distribution